Biodexa Pharmaceuticals (Biodexa Pharmaceuticals) Total Liabilities : $7.42 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Biodexa Pharmaceuticals Total Liabilities?

Biodexa Pharmaceuticals's Total Liabilities for the quarter that ended in Dec. 2023 was $7.42 Mil.

Biodexa Pharmaceuticals's quarterly Total Liabilities increased from Dec. 2022 ($2.88 Mil) to Jun. 2023 ($3.36 Mil) and increased from Jun. 2023 ($3.36 Mil) to Dec. 2023 ($7.42 Mil).

Biodexa Pharmaceuticals's annual Total Liabilities declined from Dec. 2021 ($3.27 Mil) to Dec. 2022 ($2.88 Mil) but then increased from Dec. 2022 ($2.88 Mil) to Dec. 2023 ($7.42 Mil).

Biodexa Pharmaceuticals Total Liabilities Historical Data

The historical data trend for Biodexa Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biodexa Pharmaceuticals Total Liabilities Chart

Biodexa Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

14.86

4.17

3.27

2.88

7.42

Biodexa Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial															3.27	2.70	2.88	3.36	7.42

Biodexa Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Biodexa Pharmaceuticals's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7.049	+	(0.373	+	0.00099999999999967
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	7.42

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	13.344	-	5.922
	=	7.42

Biodexa Pharmaceuticals's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7.049	+	(0.373	+	0.00099999999999967
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	7.42

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	13.344	-	5.922
	=	7.42

Biodexa Pharmaceuticals Total Liabilities Related Terms

Thank you for viewing the detailed overview of Biodexa Pharmaceuticals's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biodexa Pharmaceuticals (Biodexa Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biodexa Pharmaceuticals Plc (NAS:BDRX) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

5MP:Germany

Address

1 Caspian Point, Caspian Way, Cardiff, GBR, CF10 4DQ

Website

https://www.biodexapharma.com

Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and development medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.